J9209 HCPCS Level II code: Injection, mesna, 200 mg
J9209 is the HCPCS code for “Injection, mesna, 200 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9209Injection, mesna, 200 mg
Short description: Mesna injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9209 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1990
Where J9209 sits
- 1J codesDrugs administered other than orally
- 2Active code J9209Injection, mesna, 200 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9209 mean?
J9209 is the HCPCS code for “Injection, mesna, 200 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9209?
CMS lists J9209’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9209
All J codesJ9203Injection, gemtuzumab ozogamicin, 0.1 mgJ9204Injection, mogamulizumab-kpkc, 1 mgJ9205Injection, irinotecan liposome, 1 mgJ9206Injection, irinotecan, 20 mgJ9207Injection, ixabepilone, 1 mgJ9208Injection, ifosfamide, 1 gramJ9210Injection, emapalumab-lzsg, 1 mgJ9211Injection, idarubicin hydrochloride, 5 mgJ9212Injection, interferon alfacon-1, recombinant, 1 microgramJ9213Injection, interferon, alfa-2a, recombinant, 3 million unitsJ9214Injection, interferon, alfa-2b, recombinant, 1 million unitsJ9215Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu